Swiss Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (CHF)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/chf-corporate-healthcare-pharmaceuticals
Swiss Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (CHF) as of 2026-10-26: 10Y at 1.30%, fitted curve 3M–25Y (0.12%–1.36%), 51 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 0.12% | — |
| 6M | 0.23% | 0.35% |
| 9M | 0.34% | 0.56% |
| 18M | 0.58% | 0.85% |
| 2Y | 0.68% | 0.92% |
| 3Y | 0.83% | 1.16% |
| 4Y | 0.96% | 1.36% |
| 5Y | 1.07% | 1.49% |
| 6Y | 1.15% | 1.56% |
| 7Y | 1.21% | 1.58% |
| 8Y | 1.25% | 1.57% |
| 9Y | 1.28% | 1.55% |
| 10Y | 1.30% | 1.52% |
| 15Y | 1.35% | 1.45% |
| 20Y | 1.36% | 1.38% |
| 25Y | 1.36% | 1.36% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 0.68% and the 10-year 1.30%, a 10Y−2Y spread of +63 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 0.68% | 0.94% | 0.73% | 0.83% | 0.69% | 0.74% | 0.78% |
| 10Y | 1.30% | 1.40% | 1.26% | 1.28% | 1.16% | 1.27% | 1.23% |
| 10Y − 2Y | +63 bp | +46 bp | +53 bp | +45 bp | +47 bp | +52 bp | +45 bp |
Yields by rating group
The same curve split by credit quality: 51 rated bonds across 2 rating bands, all maturities pooled. Median yield by band: AAA to AA- 1.09%, A+ to BBB- 1.23%.
Bonds in this curve
A selection of 30 of the 51 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche | 0.26% | 2027-02-25 | 0.50% | CH1166151899 |
| DH Switzerland Finance | 0.31% | 2027-04-09 | 0.48% | CH1450810259 |
| Novartis | 0.10% | 2027-06-18 | 1.60% | CH1353257806 |
| Sandoz Group | 0.76% | 2028-03-31 | 1.25% | CH1428867027 |
| ELI Lilly | 0.32% | 2028-05-24 | 0.45% | CH0323735602 |
| Roche | 0.56% | 2028-09-15 | 1.60% | CH1305916764 |
| Galderma | 1.02% | 2028-09-27 | 1.60% | CH1373904403 |
| DH Switzerland Finance | 0.77% | 2028-12-08 | 1.12% | CH0305558030 |
| Novo Nordisk Finance | 0.74% | 2029-06-11 | 0.57% | CH1572819956 |
| Roche | 0.73% | 2029-09-06 | 0.98% | CH1371736807 |
| DH Switzerland Finance | 0.97% | 2029-10-10 | 0.89% | CH1485827336 |
| Roche | 0.75% | 2030-05-27 | 0.46% | CH1474857013 |
| Zimmer Biomet | 1.21% | 2030-09-04 | 0.93% | CH1478430742 |
| Bayer AG | 1.15% | 2030-09-11 | 1.07% | CH1478430841 |
| Novartis | 0.92% | 2031-06-18 | 1.65% | CH1353257814 |
| Roche | 0.97% | 2031-11-26 | 0.78% | CH1593191021 |
| Roche | 0.99% | 2032-09-23 | 2.00% | CH1211713230 |
| Galderma | 1.38% | 2033-03-18 | 1.81% | CH1399999981 |
| Roche | 1.08% | 2033-09-15 | 1.75% | CH1305916772 |
| DH Switzerland Finance | 1.34% | 2033-10-10 | 1.26% | CH1485827344 |
| Novartis | 1.10% | 2034-06-16 | 1.75% | CH1353257822 |
| Roche | 1.09% | 2034-09-06 | 1.10% | CH1371736815 |
| Novartis | 1.11% | 2035-05-11 | 1.05% | CH0270191007 |
| Zimmer Biomet | 1.71% | 2035-09-04 | 1.56% | CH1478430759 |
| Roche | 1.20% | 2037-02-25 | 1.00% | CH1166151915 |
| Roche | 1.28% | 2038-09-15 | 1.95% | CH1305916780 |
| Roche | 1.22% | 2039-09-06 | 1.17% | CH1371736823 |
| Novartis | 1.35% | 2040-06-18 | 1.85% | CH1353257830 |
| DH Switzerland Finance | 1.76% | 2045-10-10 | 1.94% | CH1485827369 |
| Novartis | 1.38% | 2049-06-18 | 1.85% | CH1353257848 |